Clene Inc Ordinary Shares CLNN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS
-
Clene to Present at Upcoming Investor Conferences
-
Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA
-
Clene Announces $4 Million Registered Direct Offering
-
Clene to Present at Upcoming September Investor Conferences
-
Clene to Present at the Emerging Growth Conference
-
Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights
-
Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval
Trading Information
- Previous Close Price
- $3.29
- Day Range
- $3.20–4.05
- 52-Week Range
- $3.02–13.50
- Bid/Ask
- $3.60 / $4.28
- Shares Outstanding
- 14.21M
- Market Cap
- $53.02M
- Volume/Avg
- 436 / 105,169
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 213.55
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Stock Style Box
- Small Value
- Total Number of Employees
- 79
- Website
- https://www.clene.com
Valuation
|
Metric
|
CLNN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 213.55 |
Price/Cash Flow | — |
Price/Earnings
CLNN
Financial Strength
|
Metric
|
CLNN
|
|---|---|
Quick Ratio | 2.24 |
Current Ratio | 3.07 |
Interest Coverage | −12.78 |
Quick Ratio
CLNN
Profitability
|
Metric
|
CLNN
|
|---|---|
Return on Assets (Normalized) | −105.80% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −382.52% |
Return on Assets
CLNN
Packaged Foods Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Nestle SA ADR
NSRGY
| LOCK|z<@FZx | LOCK|Hq@ | $258B | |||
| Danone SA ADR
DANOY
| LOCK|$YJrXr$ | LOCK|$!%<z | $44B | |||
| The Kraft Heinz Co
KHC
| LOCK|V@%@&dc | LOCK|&Kq$ | $28B | |||
| General Mills Inc
GIS
| LOCK|<qgxXw | LOCK|CRv# | $18B | |||
| JM Smucker Co
SJM
| LOCK|l? | LOCK|@N^ | $14B | |||
| McCormick & Co Inc Ordinary Shares (Non Voting)
MKC
| LOCK|Nnwx#Lc | LOCK|P?p | $13B | |||
| The Magnum Ice Cream Co NV
MICC
| LOCK|P<F$tH | LOCK|!p | $11B | |||
| Hormel Foods Corp
HRL
| LOCK|RtlJ<&& | LOCK|$@<J | $11B | |||
| Lamb Weston Holdings Inc
LW
| LOCK|T& | LOCK|&l$# | $7B | |||
| Ingredion Inc
INGR
| LOCK|<#L^FS<b | LOCK|<^%&P | $6B |
United States